Oxford Drug Design Limited

Active04305857 Private limited company
Incorporated
17 October 2001 (25 years)
Previously known as
Inhibox Limited (until 15 May 2017)
Industry
Research and experimental development on biotechnology (72110)
Directors
Boris Ayzikovich
Robert George Boyle
Accounts type
Micro entity
Region
South East
Address
Oxford Centre For Innovation Blue Boar Court
9 Alfred Street
Oxford
OX1 4EH

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
12 November 2027
Last conf. stmt
29 October 2026

Officers 6 active

Officer details are public data from the Companies House register.

Ayzikovich, Boris, Dr
Director · Appointed 17 September 2024
Romanian
Born February 1961 (65)
Hargreaves, Sarah Jane
Secretary · Appointed 17 April 2023
Director · Appointed 16 November 2020
Polish
Born March 1961 (65)
Boyle, Robert George
Director · Appointed 20 May 2019
British
Born October 1971 (55)
Shah, Sunil Rajen
Director · Appointed 27 March 2017
British
Born June 1973 (53)
Director · Appointed 27 February 2003
British
Born October 1958 (68)
Officer history (21 former)
12 February 2025
17 September 2024
Appointed Ayzikovich, Boris, Dr as Director
3 October 2023
Resigned Ford, David Ian as Director
17 April 2023
Appointed Hargreaves, Sarah Jane as Secretary
17 April 2023
Resigned Ip2ipo Services Limited as Corporate Director
17 April 2023
Resigned Cooper, Nikki Marie as Secretary
26 July 2022
Appointed Lyth, Oliver Robert as Director
26 July 2022
Resigned Lyth, Oliver Robert as Director
26 July 2022
Appointed Ip2ipo Services Limited as Corporate Director
31 May 2021
Resigned Haddleton & Co Limited as Corporate Secretary
31 May 2021
Appointed Cooper, Nikki Marie as Secretary
16 November 2020
Appointed Roth, Alan David, Dr as Director
5 February 2020
Appointed Haddleton & Co Limited as Corporate Secretary
5 February 2020
Resigned Ip2ipo Services Limited as Corporate Secretary
30 June 2019
Resigned Ip2ipo Services Limited as Corporate Director
20 May 2019
Appointed Ford, David Ian as Director
20 May 2019
Appointed Boyle, Robert George as Director
14 February 2018
Resigned Gorin, Igor, Dr as Director
27 March 2017
Appointed Gorin, Igor, Dr as Director
27 March 2017
Appointed Shah, Sunil Rajen as Director
15 October 2012
Resigned Davie, Paul Jonathan as Director
10 July 2012
Appointed Ip2ipo Services Limited as Corporate Director
10 July 2012
Appointed Ip2ipo Services Limited as Corporate Secretary
10 July 2012
Resigned Parish, James Maxwell as Secretary
7 June 2012
Resigned Naylor, Andrew James as Director
7 June 2012
Resigned Porter, Barry, Dr as Director
30 April 2010
Appointed Davie, Paul Jonathan as Director
25 June 2009
Appointed Naylor, Andrew James as Director
25 June 2009
Resigned Davies, John Quantrill as Director
25 June 2009
Resigned Westergren, Jussi Pekka as Director
26 March 2008
Resigned Davies, John Quantrill as Secretary
26 March 2008
Appointed Parish, James Maxwell as Secretary
1 December 2005
Appointed Porter, Barry, Dr as Director
1 December 2005
Resigned Wcphd Secretaries Limited as Corporate Secretary
1 December 2005
Appointed Davies, John Quantrill as Secretary
22 June 2005
Appointed Davies, John Quantrill as Director
22 June 2005
Resigned Norwood, David Robert as Director
24 March 2005
Appointed Westergren, Jussi Pekka as Director
17 July 2003
Resigned Askew, Herbert Frank, Dr. as Director
27 February 2003
Appointed Finn, Paul William as Director
28 October 2002
Resigned Moses, Edwin, Dr as Director
18 November 2001
Appointed Norwood, David Robert as Director
18 November 2001
Appointed Askew, Herbert Frank, Dr. as Director
18 November 2001
18 November 2001
Resigned Wcphd Directors Limited as Corporate Director
18 November 2001
Appointed Moses, Edwin, Dr as Director
17 October 2001
Appointed Wcphd Directors Limited as Corporate Director
17 October 2001
Appointed Wcphd Secretaries Limited as Corporate Secretary

Ownership 0 active

People and entities with significant control, from the Companies House PSC register

The company has declared that it has no person with significant control.
Former controllers (3)
29 July 2019
Ceased IP Venture Fund (GP) Limited — Has significant influence or control
29 July 2019
Ceased Ip2ipo Limited — Has significant influence or control
20 May 2019
Ceased Michael Underwood — Owns 25–50% of shares

Financials

Balance sheet as at 31 December 2025 · micro entity accounts

Employees
7
Current Ratio
4.5x

Trend

Shareholder Funds
£0 £500k £1.0M £1.5M £2.0M 2020 2021 2022 2023 2024 2025 £1,017,697 £376,226 £1,560,151 £774,387 £286,653 £438,861
Balance sheet detail
202520242023202220212020
Fixed Assets£805£3,557£6,159£9,906£4,088£7,879
Current Assets£564,347£548,206£839,341£1,690,572£488,959£1,282,137
Debtors£116,083£295,885£231,840£191,667£542,781
Cash£432,123£543,456£1,458,732£297,292£739,356
Creditors (< 1 year)£126,291£265,110£71,113£140,327£116,821£272,319
Net Current Assets£438,056£283,096£768,228£1,550,245£372,138£1,009,818
Shareholder Funds£438,861£286,653£774,387£1,560,151£376,226£1,017,697

Filings

Recent filings only. See the full history on Companies House

Show all recent filings

Some other companies at this address

Other companies in this industry

By trade and location

New companies in Oxford →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?